AVADEL PHARMACEUTICALS PLC — Director's Dealing 2025

Jan 28, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2025-01-24

Reporting Person: Palczuk Linda (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-24	Stock Option (Right to Buy)	$10.93	G	25000	Disposed	2034-12-17	Ordinary Shares (25000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$10.93	2034-12-17	Ordinary Shares (25000)	25000	Indirect

Footnotes

F1: The options become exercisable in three equal annual installments on each of the first three anniversaries following the 12/17/2024 grant date, subject to the Reporting Person's continued service at each such vesting date.

F2: On January 24, 2025, the Reporting Person transferred 25,000 options to a revocable trust of which the Reporting Person is trustee.